home / stock / skvi / skvi quote
Last: | $0.67 |
---|---|
Change Percent: | 0.0% |
Open: | $0 |
Close: | $0.67 |
High: | $0 |
Low: | $0 |
Volume: | 5 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.67 | $0 | $0.67 | $0 | $0 | 5 | 07-31-2024 |
$0.67 | $0 | $0.67 | $0 | $0 | 60 | 07-29-2024 |
$0.67 | $0.69 | $0.67 | $0.69 | $0.67 | 3,300 | 07-25-2024 |
$0.69 | $0.69 | $0.69 | $0.69 | $0.69 | 100 | 07-23-2024 |
$0.69 | $0 | $0.69 | $0 | $0 | 5 | 07-22-2024 |
$0.69 | $0.69 | $0.69 | $0.69 | $0.69 | 120 | 07-16-2024 |
$0.69 | $0 | $0.69 | $0 | $0 | 30 | 07-15-2024 |
$0.69 | $0.7 | $0.69 | $0.7 | $0.69 | 12,630 | 07-12-2024 |
$0.69 | $0.69 | $0.69 | $0.69 | $0.69 | 1,275 | 07-11-2024 |
$0.51 | $0.5586 | $0.51 | $0.5586 | $0.51 | 1,516 | 07-10-2024 |
$0.63 | $0.64 | $0.63 | $0.64 | $0.63 | 2,302 | 07-08-2024 |
$0.7499 | $0 | $0.7499 | $0 | $0 | 51 | 07-01-2024 |
$0.7499 | $0.7499 | $0.7499 | $0.7499 | $0.7499 | 2,009 | 06-27-2024 |
$0.7499 | $0.7499 | $0.7499 | $0.7499 | $0.7499 | 100 | 06-26-2024 |
$0.7499 | $0.7499 | $0.7499 | $0.7499 | $0.7499 | 300 | 06-25-2024 |
$0.63 | $0.3 | $0.63 | $0.63 | $0.3 | 2,000 | 06-21-2024 |
$0.51 | $0.2626 | $0.51 | $0.6 | $0.2626 | 2,400 | 06-20-2024 |
$0.75 | $0 | $0.75 | $0 | $0 | 21 | 06-17-2024 |
$0.75 | $0 | $0.75 | $0 | $0 | 1 | 06-14-2024 |
$0.75 | $0.7549 | $0.75 | $0.7549 | $0.75 | 2,345 | 06-13-2024 |
News, Short Squeeze, Breakout and More Instantly...
Results Demonstrate Significant Transdermal Performance of GLP-1 Receptor Agonists and CB-1 Receptor Antagonists Using Invisicare Technology LAS VEGAS, NV / ACCESSWIRE / July 11, 2024 / Skinvisible Pharmaceuticals, Inc. ("Skinvisible" or "the Company"), (OTCQB: SKVI ), an innovative topical ...
Results Demonstrate Significant Transdermal Penetration of GLP-1 Receptor Agonists and CB-1 Receptor Antagonists Using Invisicare Technology LAS VEGAS, NV / ACCESSWIRE / July 9, 2024 / Skinvisible Pharmaceuticals, Inc. ("Skinvisible" or "the Company"), (OTCQB: SKVI ), an innovative topical ...
Innovative Delivery System Shows Promise for GLP-1 Agonists, CB-1 Antagonists, and SGLT-2 Inhibitors LAS VEGAS, NV / ACCESSWIRE / June 24, 2024 / Skinvisible Pharmaceuticals, Inc. (OTCQB: SKVI ), an innovative topical / transdermal pharmaceutical research and development company, today anno...